Actinium Pharmaceuticals logo

Actinium Pharmaceuticals Share Price Today

(NASDAQ: ATNM)

Actinium Pharmaceuticals share price is $1.21 & ₹103.41 as on 18 Apr 2025, 2.30 'hrs' IST

$1.21

-0.04

(-3.2%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Actinium Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Actinium Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Actinium Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Actinium Pharmaceuticals share price movements

  • Today's Low: $1.17
    Today's High: $1.23

    Day's Volatility :4.88%

  • 52 Weeks Low: $1.03
    52 Weeks High: $10.24

    52 Weeks Volatility :89.95%

Actinium Pharmaceuticals (ATNM) Returns

PeriodActinium Pharmaceuticals IncIndex (Russel 2000)
3 Months
-6.92%
0.0%
6 Months
-32.02%
0.0%
1 Year
-82.34%
0.0%
3 Years
-82.98%
-12.9%

Actinium Pharmaceuticals (ATNM) Key Statistics

in dollars & INR

Previous Close
$1.25
Open
$1.23
Today's High
$1.23
Today's Low
$1.17
Market Capitalization
$37.7M
Today's Volume
$323.4K
52 Week High
$10.24
52 Week Low
$1.0292
Revenue TTM
$81.0K
EBITDA
$-41.9M
Earnings Per Share (EPS)
$-1.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-110.63%

How to invest in Actinium Pharmaceuticals Stock (ATNM) from India?

It is very easy for Indian residents to invest directly in Actinium Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Actinium Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Actinium Pharmaceuticals or ATNM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Actinium Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Actinium Pharmaceuticals shares which would translate to 0.706 fractional shares of Actinium Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Actinium Pharmaceuticals, in just a few clicks!

Returns in Actinium Pharmaceuticals (ATNM) for Indian investors in Rupees

The Actinium Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Actinium Pharmaceuticals investment value today

Current value as on today

₹20,005

Returns

₹79,995

(-79.99%)

Returns from Actinium Pharmaceuticals Stock

₹82,336 (-82.34%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Actinium Pharmaceuticals (ATNM)

143%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Actinium Pharmaceuticals Stock from India on INDmoney has increased by 143% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Actinium Pharmaceuticals

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Actinium Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Actinium Pharmaceuticals Stock (ATNM)

What analysts predicted

Upside of 313.22%

Target:

$5.00

Current:

$1.21

Insights on Actinium Pharmaceuticals Stock (Ticker Symbol: ATNM)

  • Price Movement

    In the last 1 month, ATNM stock has moved up by 3.3%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 114.0K → 81.0K (in $), with an average decrease of 29.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -11.56M → -6.65M (in $), with an average increase of 73.9% per quarter
  • ATNM vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 157.9%
  • ATNM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 111.2%
  • Price to Sales

    ForATNM every $1 of sales, investors are willing to pay $403.3, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Actinium Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Actinium Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Actinium Pharmaceuticals (ATNM) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Actinium Pharmaceuticals Inc logo
-14.18%
-32.02%
-82.34%
-82.98%
-83.33%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Actinium Pharmaceuticals

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company advances two clinical stage product candidates, Actimab-A, to treat patients with myeloid malignancies including acute myeloid leukemia and myelodysplastic syndromes; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T for various blood cancer indications and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a preclinical non-prostate specific-membrane antigen targeting radiotherapy utilizing the Actinium-225 radioisotope for patients with prostate cancer. In addition, the company's Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). Further, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies, and its research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company is based in New York, New York.
Organization
Actinium Pharmaceuticals
Employees
37
CEO
Mr. Sandesh C. Seth M.B.A., M.S.
Industry
Health Technology

Management People of Actinium Pharmaceuticals

NameTitle
Mr. Sandesh C. Seth M.B.A., M.S.
Chairman & CEO
Mr. Steven O'Loughlin BS
CFO & Corporate Secretary
Dr. Paul Diamond Esq., Ph.D.
Vice President of Patent & Legal Counsel
Dr. Avinash Desai M.D.
Chief Medical Officer
Ms. Jenny Hsieh
Chief Strategy Officer
Ms. Caroline Yarbrough
Chief Commercial Officer
Ms. Lynn M. Bodarky M.B.A.
Chief Business Officer
Mr. J. C. Simeon
Executive Director of Quality Assurance
Dr. Madhuri Vusirikala M.D.
Vice President of Clinical Development BMT & Cellular Therapy

Important FAQs about investing in ATNM Stock from India :

What is Actinium Pharmaceuticals share price today?

Actinium Pharmaceuticals share price today stands at $1.21, Open: $1.23 ; Previous Close: $1.25 ; High: $1.23 ; Low: $1.17 ; 52 Week High: $10.24 ; 52 Week Low: $1.03.

The stock opens at $1.23, after a previous close of $1.25. The stock reached a daily high of $1.23 and a low of $1.17, with a 52-week high of $10.24 and a 52-week low of $1.03.

Can Indians buy Actinium Pharmaceuticals shares?

Yes, Indians can invest in the Actinium Pharmaceuticals (ATNM) from India.

With INDmoney, you can buy Actinium Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Actinium Pharmaceuticals at zero transaction cost.

How can I buy Actinium Pharmaceuticals shares from India?

It is very easy to buy Actinium Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Actinium Pharmaceuticals (ATNM) be purchased?

Yes, you can buy fractional shares of Actinium Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Actinium Pharmaceuticals stocks?

To start investing in Actinium Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Actinium Pharmaceuticals Stock (ATNM)?

Today’s highest price of Actinium Pharmaceuticals (ATNM) is $1.23.

Today’s lowest price of Actinium Pharmaceuticals (ATNM) is $1.17.

What is today's market capitalisation of Actinium Pharmaceuticals?

Today's market capitalisation of Actinium Pharmaceuticals ATNM is 37.7M

What is the 52 Week High and Low Range of Actinium Pharmaceuticals Stock (ATNM)?

  • 52 Week High

    $10.24

  • 52 Week Low

    $1.03

What are the historical returns of Actinium Pharmaceuticals (ATNM)?

  • 1 Month Returns

    -14.18%

  • 3 Months Returns

    -32.02%

  • 1 Year Returns

    -82.34%

  • 5 Years Returns

    -83.33%

Who is the Chief Executive Officer (CEO) of Actinium Pharmaceuticals ?

Mr. Sandesh C. Seth M.B.A., M.S. is the current Chief Executive Officer (CEO) of Actinium Pharmaceuticals.